Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-30 @ 9:15 PM
Study NCT ID:
NCT03869632
Status:
UNKNOWN
Last Update Posted:
2021-11-16
First Post:
2019-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-08
First Submit QC Date:
None
Study First Post Date:
2019-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-15
Last Update Post Date:
2021-11-16
Last Update Post Date Type:
ACTUAL